The effects of tamoxifen and estrogen on brain metabolism in elderly women

Journal of the National Cancer Institute

Volumn 94, Issue 8, 2002, Pages 592-597

  Ernst, Thomas ^a   Chang, Linda ^a   Cooray, Dilrukshie ^b   Salvador, Corazon ^b   Jovicich, Jorge ^b   Walot, Irwin ^b   Boone, Kyle ^b   Chlebowski, Rowan ^b  

^a BROOKHAVEN NATIONAL LABORATORY   (United States)

^b HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE DERIVATIVE; CONJUGATED ESTROGEN; CREATINE; CREATINE PHOSPHATE; CREATININE; CYANOCOBALAMIN; FOLIC ACID; INOSITOL; MEDROXYPROGESTERONE ACETATE; N ACETYLASPARTIC ACID; PIPERAZINE ESTRONE SULFATE; TAMOXIFEN;

AGED; ANALYSIS OF VARIANCE; ARTICLE; BASAL GANGLION; BRAIN LEVEL; BRAIN METABOLISM; BRAIN REGION; BREAST CANCER; CANCER RISK; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION FUNCTION; DRUG EFFECT; DRUG SAFETY; FEMALE; FRONTAL LOBE; HIPPOCAMPUS; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; METABOLITE; NEUROTOXICITY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; STATISTICAL ANALYSIS; WHITE MATTER;

EID: 0037123338     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/94.8.592     Document Type: Article

References (37)

1. Tamoxifen in the treatment of breast cancer
2. Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study
3. Reducing the risk of breast cancer
4. Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer
5. American Society of Clinical Oncology technology assessment on breast cancer risk reduction strategies: Tamoxifen and raloxifene
6. Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention
7. Chemoprevention of breast cancer
8. Effect of estrogen on brain activation patterns in postmenopausal women during working memory tasks
9. Longitudinal effects of estrogen replacement therapy on PET cerebral blood flow and cognition
10. Effects of tamoxifen on serotonin transporter and 5-hydroxytryptamine(2A) receptor binding sites and mRNA levels in the brain of ovariectomized rats with or without acute estradiol replacement
11. Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: High-dose versus standard-dose chemotherapy
12. 1H-NMR spectroscopic studies of brain
13. Multinuclear NMR studies on the energy metabolism of glial and neuronal cells
14. The biochemistry of living tissues: Examination by MRS
15. The metabolism of choline
16. Proton spectroscopy in myotonic dystrophy: Correlation with CTG repeats
17. Cerebral metabolite abnormalities correlate with clinical severity of HIV-1 cognitive motor complex
18. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician
19. Spatial localization in NMR spectroscopy in vivo
20. Elimination of artifacts in short echo time H MR spectroscopy of the frontal lobe
21. Absolute quantitation of water and metabolites in the human brain. I. Compartments and water
22. Reproducibility of 1H-MRS in vivo
23. In vivo proton magnetic resonance spectroscopy of the normal aging human brain
24. Neuroprotective effects of estradiol in the adult rat hippocampus: Interaction with insulin-like growth factor-I signalling
25. Neuroprotection by estrogens in a mouse model of focal cerebral ischemia and in cultured neurons: Evidence for a receptor-independent antioxidative mechanism
26. Estradiol protects mesencephalic dopaminergic neurons from oxidative stress-induced neuronal death
27. Protective action of 17beta-estradiol and tamoxifen on glutamate toxicity in glial cells
28. Role of astroglia in estrogen regulation of synaptic plasticity and brain repair
29. Reactive astrocytes express estrogen receptors in the injured primate brain
30. Estrogen, progestogen and tamoxifen increase synaptic density of the hippocampus of ovariectomized rats
31. Increases of glial fibrillary acidic protein in the aging female mouse brain
32. Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma
33. The relationship of tamoxifen with dementia, depression, and dependence in activities of daily living in elderly nursing home residents
34. Health-related quality of life and tamoxifen in breast cancer prevention: A report from the National Surgical Adjuvant Breast and Bowel Project P-1 Study
35. Preliminary assessment of cognitive function in breast cancer patients treated with tamoxifen
36. Cognitive and motor functioning in Parkinson disease: Subjects with and without questionable dementia